Literature DB >> 12780783

Mechanism of action of purine analogues in chronic lymphocytic leukaemia.

Andrew R Pettitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12780783     DOI： 10.1046/j.1365-2141.2003.04336.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.

Authors:  Deepa Sampath; William Plunkett
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

Review 3.  Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.

Authors:  Tadeusz Robak
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.

Authors:  S H Tonino; J van Laar; M H van Oers; J Y Wang; E Eldering; A P Kater
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

Review 5.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

6.  Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.

Authors:  Jonathan S Serody; Ivana Gojo; Joshua F Zeidner; Benjamin G Vincent; Anastasia Ivanova; Dominic Moore; Karen P McKinnon; Alec D Wilkinson; Rupkatha Mukhopadhyay; Francesco Mazziotta; Hanna A Knaus; Matthew C Foster; Catherine C Coombs; Katarzyna Jamieson; Hendrik Van Deventer; Jonathan A Webster; Gabrielle T Prince; Amy E DeZern; B Douglas Smith; Mark J Levis; Nathan D Montgomery; Leo Luznik
Journal:  Blood Cancer Discov       Date:  2021-09-10

7.  Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice.

Authors:  Shinnosuke Tsuji; Calvin J Stephens; Giulia Bortolussi; Feijie Zhang; Gabriele Baj; Hagoon Jang; Gustavo de Alencastro; Andrés F Muro; Katja Pekrun; Mark A Kay
Journal:  Nat Biotechnol       Date:  2022-04-07       Impact factor: 68.164

8.  Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.

Authors:  Kensuke Kojima; Marina Konopleva; Teresa McQueen; Susan O'Brien; William Plunkett; Michael Andreeff
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

Review 9.  Augmenting antitumor immune responses with epigenetic modifying agents.

Authors:  Erika Héninger; Timothy E G Krueger; Joshua M Lang
Journal:  Front Immunol       Date:  2015-02-04       Impact factor: 7.561

10.  Adenosine deaminase activity modulation by some street drug: molecular docking simulation and experimental investigation.

Authors:  Massoud Amanlou; Ali-akbar Saboury; Roya Bazl; Mohammad Reza Ganjali; Shokoofeh Sheibani
Journal:  Daru       Date:  2014-05-02       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.